Do analysts recommend ZJYL or BDMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, ZJYL or BDMD?

Jin Medical International has higher earnings, but lower revenue than Baird Medical Investment. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 7.43 $1.19M N/A N/A Baird Medical Investment $24.49M 1.73 N/A N/A N/A

Is ZJYL or BDMD more profitable?

Company Net Margins Return on Equity Return on Assets Jin Medical International N/A N/A N/A Baird Medical Investment N/A N/A N/A

Do analysts prefer BDMD or FOCL?

FocalTherics has a consensus target price of $7.75, indicating a potential upside of 86.30%. Given FocalTherics' stronger consensus rating and higher possible upside, analysts plainly believe FocalTherics is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 FocalTherics 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.40

Which has stronger valuation and earnings, BDMD or FOCL?

Baird Medical Investment has higher earnings, but lower revenue than FocalTherics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $24.49M 1.73 N/A N/A N/A FocalTherics $79.31M 1.97 -$29.25M -$1.03 N/A

Do analysts prefer BDMD or KRMD?

KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 117.39%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KORU Medical Systems 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Which has stronger earnings and valuation, BDMD or KRMD?

Baird Medical Investment has higher earnings, but lower revenue than KORU Medical Systems. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $24.49M 1.73 N/A N/A N/A KORU Medical Systems $45.11M 3.28 -$2.64M -$0.04 N/A

Does the media refer more to BDMD or KRMD?

In the previous week, Baird Medical Investment had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for Baird Medical Investment and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat Baird Medical Investment's score of -0.25 indicating that KORU Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend BDMD or INGN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better earnings and valuation, BDMD or INGN?

Baird Medical Investment has higher earnings, but lower revenue than Inogen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $24.49M 1.73 N/A N/A N/A Inogen $348.67M 0.39 -$22.75M -$0.90 N/A

Does the media refer more to BDMD or INGN?

In the previous week, Baird Medical Investment had 2 more articles in the media than Inogen. MarketBeat recorded 3 mentions for Baird Medical Investment and 1 mentions for Inogen. Inogen's average media sentiment score of 0.00 beat Baird Medical Investment's score of -0.25 indicating that Inogen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inogen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate BDMD or OWLT?

Owlet has a consensus price target of $15.00, indicating a potential upside of 209.92%. Given Owlet's stronger consensus rating and higher possible upside, analysts plainly believe Owlet is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Owlet 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has higher valuation and earnings, BDMD or OWLT?

Baird Medical Investment has higher earnings, but lower revenue than Owlet. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $24.49M 1.73 N/A N/A N/A Owlet $114.41M 1.24 -$39.68M -$0.75 N/A

Does the media favor BDMD or OWLT?

In the previous week, Baird Medical Investment and Baird Medical Investment both had 3 articles in the media. Owlet's average media sentiment score of 0.51 beat Baird Medical Investment's score of -0.25 indicating that Owlet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Owlet 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Baird Medical Investment (BDMD) Competitors

$1.01 -0.04 (-4.19%)

As of 10:26 AM Eastern

Compare

BDMD vs. ZJYL, FOCL, KRMD, INGN, and OWLT

Should you buy Baird Medical Investment stock or one of its competitors? Baird Medical Investment's main competitors and comparable companies include Jin Medical International (ZJYL), FocalTherics (FOCL), KORU Medical Systems (KRMD), Inogen (INGN), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Baird Medical Investment compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

Jin Medical International has higher earnings, but lower revenue than Baird Medical Investment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	7.43	$1.19M	N/A	N/A
Baird Medical Investment	$24.49M	1.73	N/A	N/A	N/A

19.8% of Baird Medical Investment shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jin Medical International has a beta of 7.31, suggesting that its stock price is 631% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.15, suggesting that its stock price is 215% less volatile than the broader market.

In the previous week, Baird Medical Investment had 3 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for Baird Medical Investment and 0 mentions for Jin Medical International. Jin Medical International's average media sentiment score of -0.25 beat Baird Medical Investment's score of -0.25 indicating that Jin Medical International is being referred to more favorably in the media.

Company	Overall Sentiment
Jin Medical International	Neutral
Baird Medical Investment	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Baird Medical Investment	N/A	N/A	N/A

Summary

Baird Medical Investment beats Jin Medical International on 4 of the 7 factors compared between the two stocks.

How does Baird Medical Investment compare to FocalTherics?

Baird Medical Investment (NASDAQ:BDMD) and FocalTherics (NASDAQ:FOCL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Baird Medical Investment has a net margin of 0.00% compared to FocalTherics' net margin of -56.26%. Baird Medical Investment's return on equity of 0.00% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
FocalTherics	-56.26%	-248.00%	-44.69%

FocalTherics has a consensus target price of $7.75, indicating a potential upside of 86.30%. Given FocalTherics' stronger consensus rating and higher possible upside, analysts plainly believe FocalTherics is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 10.1% of FocalTherics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Baird Medical Investment had 3 more articles in the media than FocalTherics. MarketBeat recorded 3 mentions for Baird Medical Investment and 0 mentions for FocalTherics. FocalTherics' average media sentiment score of 0.00 beat Baird Medical Investment's score of -0.25 indicating that FocalTherics is being referred to more favorably in the news media.

Company	Overall Sentiment
Baird Medical Investment	Neutral
FocalTherics	Neutral

Baird Medical Investment has a beta of -1.15, indicating that its share price is 215% less volatile than the broader market. Comparatively, FocalTherics has a beta of -0.07, indicating that its share price is 107% less volatile than the broader market.

Baird Medical Investment has higher earnings, but lower revenue than FocalTherics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$24.49M	1.73	N/A	N/A	N/A
FocalTherics	$79.31M	1.97	-$29.25M	-$1.03	N/A

Summary

FocalTherics beats Baird Medical Investment on 9 of the 14 factors compared between the two stocks.

How does Baird Medical Investment compare to KORU Medical Systems?

Baird Medical Investment (NASDAQ:BDMD) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

In the previous week, Baird Medical Investment had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for Baird Medical Investment and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat Baird Medical Investment's score of -0.25 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baird Medical Investment has a beta of -1.15, meaning that its share price is 215% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market.

Baird Medical Investment has higher earnings, but lower revenue than KORU Medical Systems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$24.49M	1.73	N/A	N/A	N/A
KORU Medical Systems	$45.11M	3.28	-$2.64M	-$0.04	N/A

KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 117.39%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Baird Medical Investment has a net margin of 0.00% compared to KORU Medical Systems' net margin of -4.03%. Baird Medical Investment's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
KORU Medical Systems	-4.03%	-10.63%	-6.51%

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

KORU Medical Systems beats Baird Medical Investment on 8 of the 13 factors compared between the two stocks.

How does Baird Medical Investment compare to Inogen?

Baird Medical Investment (NASDAQ:BDMD) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Baird Medical Investment has a beta of -1.15, indicating that its stock price is 215% less volatile than the broader market. Comparatively, Inogen has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

In the previous week, Baird Medical Investment had 2 more articles in the media than Inogen. MarketBeat recorded 3 mentions for Baird Medical Investment and 1 mentions for Inogen. Inogen's average media sentiment score of 0.00 beat Baird Medical Investment's score of -0.25 indicating that Inogen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inogen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 2.5% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Baird Medical Investment has higher earnings, but lower revenue than Inogen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$24.49M	1.73	N/A	N/A	N/A
Inogen	$348.67M	0.39	-$22.75M	-$0.90	N/A

Baird Medical Investment has a net margin of 0.00% compared to Inogen's net margin of -6.94%. Baird Medical Investment's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Inogen	-6.94%	-13.17%	-8.36%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Baird Medical Investment and Inogen tied by winning 6 of the 12 factors compared between the two stocks.

How does Baird Medical Investment compare to Owlet?

Baird Medical Investment (NASDAQ:BDMD) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Owlet has a consensus price target of $15.00, indicating a potential upside of 209.92%. Given Owlet's stronger consensus rating and higher possible upside, analysts plainly believe Owlet is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Baird Medical Investment has a net margin of 0.00% compared to Owlet's net margin of -8.61%. Baird Medical Investment's return on equity of 0.00% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Owlet	-8.61%	-601.24%	-15.96%

In the previous week, Baird Medical Investment and Baird Medical Investment both had 3 articles in the media. Owlet's average media sentiment score of 0.51 beat Baird Medical Investment's score of -0.25 indicating that Owlet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Owlet	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baird Medical Investment has a beta of -1.15, suggesting that its stock price is 215% less volatile than the broader market. Comparatively, Owlet has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Baird Medical Investment has higher earnings, but lower revenue than Owlet.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$24.49M	1.73	N/A	N/A	N/A
Owlet	$114.41M	1.24	-$39.68M	-$0.75	N/A

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Owlet beats Baird Medical Investment on 7 of the 12 factors compared between the two stocks.

Get Baird Medical Investment News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BDMD vs. The Competition

Export

Metric	Baird Medical Investment	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$42.63M	$5.49B	$7.25B	$13.11B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	N/A	25.35	275.80	25.68
Price / Sales	1.73	73.63	690.09	98.91
Price / Cash	N/A	33.11	28.04	34.72
Price / Book	N/A	5.91	10.60	6.35
Net Income	N/A	$151.55M	$3.50B	$358.31M
7 Day Performance	-5.09%	0.15%	-0.06%	1.07%
1 Month Performance	-13.28%	-3.86%	-2.50%	-2.66%
1 Year Performance	-61.89%	6.95%	18.51%	6.11%

Baird Medical Investment Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BDMD Baird Medical Investment	1.0713 of 5 stars	$1.01 -4.2%	N/A	-60.2%	$42.63M	$24.49M	N/A	146
ZJYL Jin Medical International	0.9021 of 5 stars	$1.97 -1.0%	N/A	-82.5%	$154.51M	$20.69M	N/A	273
FOCL FocalTherics	3.6206 of 5 stars	$4.07 -0.2%	$7.75 +90.4%	N/A	$152.75M	$70.53M	N/A	230	Gap Up
KRMD KORU Medical Systems	3.7195 of 5 stars	$3.20 +1.3%	$7.00 +118.8%	-22.4%	$146.98M	$41.13M	N/A	73	Positive News
INGN Inogen	0.4657 of 5 stars	$5.13 -1.3%	N/A	-40.6%	$136.14M	$354.30M	N/A	753	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BDMD) was last updated on 9/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baird Medical Investment (BDMD) Competitors

BDMD vs. ZJYL, FOCL, KRMD, INGN, and OWLT

How does Baird Medical Investment compare to Jin Medical International?

Summary

How does Baird Medical Investment compare to FocalTherics?

Summary

How does Baird Medical Investment compare to KORU Medical Systems?

Summary

How does Baird Medical Investment compare to Inogen?

Summary

How does Baird Medical Investment compare to Owlet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baird Medical Investment (BDMD) Competitors

BDMD vs. ZJYL, FOCL, KRMD, INGN, and OWLT

How does Baird Medical Investment compare to Jin Medical International?

Which has better valuation and earnings, ZJYL or BDMD?

Do insiders & institutionals hold more shares of ZJYL or BDMD?

Do analysts recommend ZJYL or BDMD?

Which has more volatility & risk, ZJYL or BDMD?

Does the media favor ZJYL or BDMD?

Is ZJYL or BDMD more profitable?

Summary

How does Baird Medical Investment compare to FocalTherics?

Is BDMD or FOCL more profitable?

Do analysts prefer BDMD or FOCL?

Do insiders and institutionals have more ownership in BDMD or FOCL?

Does the media refer more to BDMD or FOCL?

Which has more volatility and risk, BDMD or FOCL?

Which has stronger valuation and earnings, BDMD or FOCL?

Summary

How does Baird Medical Investment compare to KORU Medical Systems?

Does the media refer more to BDMD or KRMD?

Which has more risk and volatility, BDMD or KRMD?

Which has stronger earnings and valuation, BDMD or KRMD?

Do analysts prefer BDMD or KRMD?

Is BDMD or KRMD more profitable?

Do institutionals and insiders hold more shares of BDMD or KRMD?

Summary

How does Baird Medical Investment compare to Inogen?

Which has more risk and volatility, BDMD or INGN?

Does the media refer more to BDMD or INGN?

Do insiders & institutionals hold more shares of BDMD or INGN?

Which has better earnings and valuation, BDMD or INGN?

Is BDMD or INGN more profitable?

Do analysts recommend BDMD or INGN?

Summary

How does Baird Medical Investment compare to Owlet?

Do analysts rate BDMD or OWLT?

Is BDMD or OWLT more profitable?

Does the media favor BDMD or OWLT?

Which has more volatility and risk, BDMD or OWLT?

Which has higher valuation and earnings, BDMD or OWLT?

Do institutionals & insiders believe in BDMD or OWLT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools